WELCOME TO TFDA

Tanzania Food and Drugs Authority (TFDA) is a regulatory body under the Ministry of Health and Social Welfare which is responsible for regulating the quality and safety of food, drugs, cosmetics and medical devices. more about TFDA
Thank you for visiting our website
ADVERSE EFFECTS
Have you suffered an adverse drug reaction? If so please consult your healthcare provider to fill the ADR form on-line. or  download the form, have it filled by your healthcare provider and send it to us.
[more about Adverse Drug Reaction]
VISITOR TO THIS SITE
Total Visitors: 
There are    visitors visited our site until now
Total Guests: 0
There are 0 guests viewing the site
PUBLIC EDUCATION

The authority provides education to the public about food, drugs, cosmetics and medical devices. For more information   Click here  

TANZANIA NATIONAL FORMULARY (TNF 2nd Edition)

Introduction
The Tanzania National Formulary (TNF) is published by the Ministry of Health through the Tanzania Food and Drugs Authority (TFDA). It aims at providing up-to-date, unbiased and evidence-based drug information which will promote safe, rational and effective use of drugs in the community.

The first edition of TNF was published in 1998. Since then great strides have been made in medicine and pharmacy such as emergency of new diseases, changes of treatment guidelines and occurrence of resistant microbes. These changes led to the development of new products and discovery of new adverse reactions and interactions. Therefore it has become necessary to revise and update the information of the TNF.

The second edition of TNF was published in 2005. Among many changes in this edition, it features new policy guidelines for treatment of malaria, management of HIV infection using Anti-Retroviral Drugs and entries of other drugs including new chapters on drugs for genitourinary disorders and diagnostics. New appendices on drugs use in hepatic and renal impairment had been added. Furthermore, drugs found to be associated with frequent adverse reactions and which had been withdrawn from the market, were omitted.

How To Use Tanzania National Formulary
The Tanzania National Formulary is divided into the following sections:

  1. Guidelines on prescribing: Prescribers are given general information on how to prescribe drugs.
  2. Guidelines on dispensing:  Information on how to dispense drugs, including controlled drugs is provided in this section.
  3. Guidelines on the monitoring of adverse drug reactions:  This gives general guidelines on the types of adverse reactions to be reported and how to report.
  4. Information on drugs:  Drug monographs in each chapter are arranged alphabetically and contain the following subtitles:
    1. Indications:  This contains the main indications for the drug. 
    2. Dose:  The doses shown are intended for general guidance only.  Factors such as the severity of the disease state and the patients’ renal or hepatic function may change the dose.
    3. Precautions:  These are intended to caution the prescriber to reduce the dose or increase interval between doses or choose another drug according to the patient’s condition and monitoring measures to make when the patients is using this drugs
    4. Contraindications:  These are intended to warn the prescriber that usage of the drug may bring harm to the patient.
    5. Adverse effects:  These are intended to guide the prescriber on what to expect when a drug is used.  The list is not comprehensive and new ones may be encountered which should be reported to TADATIS immediately.
    6. Overdosage:  An outline on how to manage drug overdosage is provided.
    7. Storage:  This has been included on drugs needing special storage conditions; otherwise all drugs should be stored at temperatures between 15-300C.
    8. Preparations:  Preparations are written under their generic names.  Letters A or B or C or D are written beside the preparation.  This denotes the level the drug is prescribable as follows;-

      A = dispensary
      B = health centre
      C = District and Sub-district level
      D = Regional and referral hospitals
      * Preparations without letters are not in the National Essential Drug List (NEDLIT)

  5. Appendices: The appendices give information on drug interactions, drugs and pregnancy, drugs and breast-feeding, drug use in renal and liver diseases and ADR reporting form.
  6. Index:  Drugs have been listed in alphabetical order.
  1. Kuruhusu Uagizaji, Usambazaji, Uuzaji na Matumizi ya Dawa ya Kutibu Malaria ya Vidonge ya Metakelfin Kutoka Kampuni ya Pfizer Inc. N/Y Inayotengenezwa na Kiwanda cha Dawa cha Pharmacia & Upjohn cha Italia
    (Posted: 1st Septemba, 2010 )

  2. a) Maelezo ya Utangulizi ya Kaimu Mkurugenzi Mkuu wa TFDA, Bw. Hiiti B. Sillo Katika Mkutano wa Waandishi wa Habari Kuhusu Matokeo ya Operesheni Mamba III Katika Ukumbi wa Mamlaka ya Chakula Na Dawa, Tarehe 26 Agosti 2010.

    b) Taarifa kwa Umma Kuhusu Matokeo ya Operesheni Mamba Awamu ya Tatu Itakayotolewa Na Mkurugenzi wa Upelelezi wa Makosa ya Jinai Kamishna wa Polisi Robert Manumba Katika Ukumbi wa Mamlaka ya Chakula na Dawa Tarehe 26 Agosti 2010.
    (Posted: 26th August, 2010 )

  3. Taarifa kwa Umma Kuhusu Kuwepo katika soko Vyakula ambavyo ni Bandia au ambavyo Havijasajiliwa
    (Posted: 13th August, 2010 )

  4. Kusitisha na kudhibiti matumizi ya sindano za kawaida (Standard Disposable Syringes) na kuimarisha matumizi ya
    Sindano zinazojiharibu baada ya matumizi (Autodisable Syringes)
    (Posted: 6th Mei, 2010 )

  5. Huishwaji wa Vibali vya viwanda vya kusindika/kutengeneza vyakula kwa mwaka 2010/2011
    (Posted: 1st Aprili, 2010 )

  6. Renewal of Business Permit for Local Food Processors Manufacturers for the year 2010/2011
    (Posted: 1st April, 2010 )

  7. Phasing Out and Limiting use of Standard Disposable Syringes in favour of Autodisable Syringes
    (Posted: 22nd April, 2010 )

WHO IS WHO AT TFDA ?
 
copyrights ©2004  All rights reserved Privacy policy . Our website:  www.tfda.or.tz
POWERED BY TFDA